title: Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy.
authors: José M
authors: JM
authors: Ruiz-Moreno
authors: Javier A
authors: JA
authors: Montero
authors: Francisco
authors: F
authors: Lugo
authors: Pedro
authors: P
authors: Amat
authors: Corina
authors: C
authors: Staicu
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D048909:Diabetes Complications; D006801:Humans; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000276:immunology; D014821:Vitrectomy; D014822:Vitreous Body / Q000187:drug effects; D014823:Vitreous Hemorrhage / Q000209:etiology* / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab